SCHEMBL69992

SCHEMBL69992

CCc1cc(C)c(O)cc1O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 1/20 0.47
MCL1 Q07820 2/20 0.47
MAPT P10636 5/20 0.44
KDM4E B2RXH2 4/20 0.44
MAPK1 P28482 4/20 0.44
HSD17B10 Q99714 3/20 0.44
ALOX15 P16050 3/20 0.44
ALDH1A1 P00352 3/20 0.44
HPGD P15428 2/20 0.44
ALOX12 P18054 2/20 0.44
PKM P14618 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
G6PD P11413 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
CCR6 P51684 1/20 0.44
HIF1A Q16665 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9231605 0.90 KDM4E (0.50) SHBGMCL1MAPTKDM4EMAPK1
SCHEMBL6151944 0.87 ALOX15 (0.52) SHBGMCL1MAPTKDM4EMAPK1
SCHEMBL30309307 0.87 MCL1 (0.48) SHBGMCL1MAPTKDM4EMAPK1
SCHEMBL4092415 0.87 MCL1 (0.48) SHBGMCL1MAPTKDM4EMAPK1
SCHEMBL45886 0.85 MCL1 (0.47) SHBGMCL1MAPTKDM4EMAPK1
SCHEMBL11076422 0.85 NPSR1 (0.50) MCL1MAPTKDM4EMAPK1HSD17B10
SCHEMBL26834212 0.84 MAPT (0.44) SHBGMCL1MAPTKDM4EMAPK1
SCHEMBL16073096 0.84 MCL1 (0.43) SHBGMCL1MAPTKDM4EMAPK1
SCHEMBL11038842 0.84 ESR1 (0.48) SHBGMCL1MAPTKDM4EMAPK1
SCHEMBL19765492 0.83 ALOX15 (0.54) SHBGMCL1MAPTKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9235116-B2 Actinic-ray- or radiation sensitive resin composition, actinic-ray- or radiation-sensitive film therefrom and method of forming pattern FUJIFILM CORPORATION (JP) 2016-01-12 US disclosed
EP-2332909-B1 HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90 ASTEX THERAPEUTICS LTD (GB) 2014-10-15 EP disclosed
EP-2479203-A1 AROMATIC POLYESTER Muroran Institute of Technology (JP) 2012-07-25 EP disclosed
US-20120172570-A1 AROMATIC POLYESTER NITTA CORPORATION 2012-07-05 US disclosed
US-8129493-B2 Aromatic polyester MURORAN INSTITUTE OF TECHNOLOGY (JP) 2012-03-06 US disclosed
US-20110224343-A1 MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME MURORAN INSTITUTE OF TECHNOLOGY (JP) 2011-09-15 US disclosed
US-20110092662-A1 AROMATIC POLYESTER NITTA CORPORATION (JP) 2011-04-21 US disclosed
EP-1345943-B1 INHIBITORS OF PAPILLOMA VIRUS BOEHRINGER INGELHEIM CA LTD (CA) 2007-03-21 EP disclosed
US-7169957-B2 Substantially spherical supramolecular assemblies ATWOOD JERRY L 2007-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224343-A1 MODIFIER FOR AROMATIC POLYESTER AND AROMATIC POLYESTER RESIN COMPOSITION COMPRISING THE SAME F12, PHAX, WDR82 SHBG 4659/4885MCL1 4705/4885MAPT 1923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.